Wen-Kai Shi

机构：Guangdong Pharmaceutical University, Lanzhou Jiaotong University, Alibaba Group (China)

发表论文 11 篇 · 总被引 631 次 · h-index 6

代表论文

• miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a (2018 · Journal of Hematology & Oncology · 被引 241)
• Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations (2021 · Liver Cancer · 被引 238)
• NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma (2020 · Cell Death and Disease · 被引 59)
• Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma. (2017 · PubMed · 被引 33)
• SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4 (2022 · Oncology Reports · 被引 29)
• Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a (2018 · Journal of Hematology & Oncology · 被引 20)